LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free LMAT Stock Alerts $66.70 -0.14 (-0.21%) (As of 03/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 7EstimatedActual EPS (Feb. 27) $0.38 Beat By $0.02 Consensus EPS (Feb. 27) $0.36 Read Call TranscriptListen to Call Get LeMaitre Vascular Earnings AlertsEnter your email address below to receive the latest news and earnings results for LMAT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLMAT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LMAT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy LeMaitre Vascular Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.40$0.40$0.400.360 - 0.410Q2 20241$0.47$0.47$0.47 Q3 20241$0.40$0.40$0.40 Q4 20241$0.41$0.41$0.41 FY 20244$1.68$1.68$1.68 Q1 20251$0.44$0.44$0.44 Q2 20251$0.51$0.51$0.51 Q3 20251$0.44$0.44$0.44 Q4 20251$0.47$0.47$0.47 FY 20254$1.86$1.86 $1.86LMAT Earnings Date and InformationLeMaitre Vascular last announced its earnings data on February 27th, 2024. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The company earned $48.90 million during the quarter, compared to analysts' expectations of $49.01 million. Its revenue was up 19.3% on a year-over-year basis. LeMaitre Vascular has generated $1.34 earnings per share over the last year ($1.34 diluted earnings per share) and currently has a price-to-earnings ratio of 49.8. Earnings for LeMaitre Vascular are expected to grow by 9.64% in the coming year, from $1.66 to $1.82 per share. LeMaitre Vascular has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off prior year's report dates.Read More LeMaitre Vascular Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/7/2024Estimated)------- 2/27/2024Q4 2023$0.36$0.38+$0.02$0.38$49.01 million$48.90 million 11/1/2023Q3 2023$0.31$0.33+$0.02$0.33$47.58 million$47.40 million 8/1/2023Q2 2023$0.32$0.37+$0.05$0.38$48.29 million$50.12 million5/2/2023Q1 2023$0.25$0.27+$0.02$0.27$43.54 million$47.08 million 2/23/2023Q4 2022$0.26$0.25($0.01)$0.25$40.99 million$41.00 million 10/27/2022Q3 2022$0.28$0.25($0.03)$0.25$40.13 million$39.03 million Get the Latest News and Ratings for LMAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter. 7/28/2022Q2 2022$0.32$0.29($0.03)$0.42$41.26 million$42.11 million4/28/2022Q1 2022$0.28$0.27($0.01)$0.27$38.65 million$39.56 million 2/24/2022Q4 2021$0.31$0.28($0.03)$0.28$39.70 million$39.50 million 10/28/2021Q3 2021$0.33$0.30($0.03)$0.30$39.05 million$38.37 million 7/29/2021Q2 2021$0.34$0.40+$0.06$0.40$40.70 million$40.67 million 4/29/2021Q1 2021$0.28$0.28-$0.28$35.55 million$35.88 million LeMaitre Vascular Earnings - Frequently Asked Questions When is LeMaitre Vascular's earnings date? LeMaitre Vascular has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off last year's report dates. Learn more on LMAT's earnings history. Did LeMaitre Vascular beat their earnings estimates last quarter? In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) reported $0.38 earnings per share (EPS) to beat the analysts' consensus estimate of $0.36 by $0.02. Learn more on analysts' earnings estimate vs. LMAT's actual earnings. How can I listen to LeMaitre Vascular's earnings conference call? The conference call for LeMaitre Vascular's latest earnings report can be listened to online. Listen to Conference Call How can I read LeMaitre Vascular's conference call transcript? The conference call transcript for LeMaitre Vascular's latest earnings report can be read online. Read Transcript How much revenue does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $193.48 million. How much profit does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $30.10 million. LMAT has generated $1.34 earnings per share over the last four quarters. What is LeMaitre Vascular's price-to-earnings ratio? LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 49.78 and a forward price-to-earnings ratio of 40.18. The price/earnings-to-growth ratio is 2.91. What is LeMaitre Vascular's EPS forecast for next year? LeMaitre Vascular's earnings are expected to grow from $1.66 per share to $1.82 per share in the next year, which is a 9.64% increase. More Earnings Resources from MarketBeat Related Companies: NVCR Earnings ATRC Earnings MDXG Earnings ATEC Earnings TNDM Earnings FNA Earnings AORT Earnings EMBC Earnings ATRI Earnings TMCI Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earningsBeyond Nvidia: The hidden stars with 200% earnings growth This page (NASDAQ:LMAT) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Gates Bets on $15 Trillion BonanzaWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.